R-Nanochop Incorporating a TFR1-Targeted Doxorubicin Nanocarrier Is Superior to R-CHOP in a PDX Model of Diffuse Large B-Cell Lymphoma
Year: 2020
Type: conference-abstract
Source: Blood
Institutions: University of Miami, Sylvester Comprehensive Cancer Center
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W3095383846
